Jeff Garro Analyst Performance

Managing Director at Stephens

Jeff Garro is a stock analyst at Stephens across a range of sectors, covering 9 publicly traded companies. Over the past year, Jeff Garro has issued 11 stock ratings, including buy and hold recommendations. While full access to Jeff Garro's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jeff Garro's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 13 Last 4 Years
Buy Recommendations: 46.15% 6 Buy Ratings
Companies Covered: 9 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	46.2%	6 ratings
Hold	53.8%	7 ratings
Sell	0.0%	0 ratings

Out of 13 total stock ratings issued by Jeff Garro at Stephens, the majority (53.8%) have been Hold recommendations, followed by 46.2% Buy.

Best & Worst Calls

Best Call
000.0%
SLQT
Aug 2021
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	66.7% of companies on NASDAQ	6 companies
NYSE	33.3% of companies on NYSE	3 companies

Jeff Garro, an analyst at Stephens, currently covers 9 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 5 companies	55.6%
	Computer and Technology 2 companies	22.2%
	Business Services 1 company	11.1%
	Finance 1 company	11.1%

Jeff Garro of Stephens specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and Business Services companies.

Coverage Industries

Industry	Percentage
MEDICAL INFO SYS 4 companies	44.4%
INTERNET SOFTWARE 1 company	11.1%
COMP - SOFTWARE 1 company	11.1%
MED - BIOMED/GENE 1 company	11.1%
COMPUTER INTEGRATED SYSTEMS DESIGN 1 company	11.1%
INS - MULTI LINE 1 company	11.1%

About Jeff Garro

Jeff Garro, CFA is a Managing Director and equity research analyst covering Healthcare IT. Jeff joined Stephens in September 2022 from previous research analyst roles at Piper Sandler, and William Blair, and has covered healthcare IT stocks since 2009. Prior to equity research, Jeff worked as a litigation attorney. Jeff received his B.S.E. in Biomedical and Electrical Engineering from Duke University in 2004 and his J.D. from DePaul University in 2007.

Follow on LinkedIn

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
PRVA Privia Health Group	9/24/2025	Reiterated Rating	$23.48	$32.00	Overweight
EVH Evolent Health	9/24/2025	Reiterated Rating	$8.41	$9.00	Equal Weight
PRVA Privia Health Group	9/4/2025	Reiterated Rating	$23.17	$32.00	Overweight
PHR Phreesia	9/3/2025	Reiterated Rating	$31.47	$32.00	Overweight
SLP Simulations Plus	7/15/2025	Lower Price Target	$17.47	$20.00	Overweight
TBRG TruBridge	4/10/2025	Reiterated Rating	$25.87	$28.00	Equal Weight
TBRG TruBridge	3/11/2025	Boost Price Target	$30.55	$28.00	Equal Weight
HCAT Health Catalyst	3/6/2025	Lower Price Target	$4.52	$5.00	Equal Weight
HCAT Health Catalyst	2/27/2025	Reiterated Rating	$4.13	$7.00	Equal Weight
CERT Certara	2/27/2025	Reiterated Rating	$12.39	$17.00	Overweight
MDRX Veradigm	1/31/2025	Boost Price Target	$4.78	$13.00	Equal Weight

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.